Navigation Links
Abbott Declares 339th Consecutive Quarterly Dividend
Date:9/12/2008

ABBOTT PARK, Ill., Sept. 12 /PRNewswire-FirstCall/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 36 cents per share.

This marks the 339th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Nov. 15, 2008, to shareholders of record at the close of business on Oct. 15, 2008.

Abbott has increased its dividend payout for 36 consecutive years -- including a 10.8 percent increase earlier this year -- and was named to the Fortune 40: Best stocks to retire on. Additionally, since the debut of the S&P 500 in 1957, Abbott has had the second-highest average annual return of all originally listed companies, in part because of its dividend yield.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs more than 68,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at http://www.abbott.com.


'/>"/>
SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania
2. Abbott Donates Diagnostic Instruments As Part of the Labs Are Vital(TM) Initiative
3. Novel Diagnostic Marker for Acute Kidney Injury Previewed at Abbott-Sponsored Scientific Workshop
4. Abbott Fund and the Government of Tanzania Celebrate Milestone in Strengthening Nations Health Care System
5. Abbott to Preview New CELL-DYN(R) Emerald(TM) Hematology Instrument
6. Abbott and Partnership for a Drug-Free America Launch Not In My House to Help Parents Secure Their Homes from Teen Prescription Drug Misuse and Abuse
7. Data Show that Abbotts HUMIRA(R) (adalimumab) Reduced the Signs and Symptoms of Ankylosing Spondylitis Up to Three Years
8. Abbott Opens New State-of-the-Art R&D Facility to Help Bring Medicines to Patients Faster
9. Now Playing: Spike Lee Stands with Earvin Magic Johnson, Cookie Johnson and Abbott to Launch National PSA Campaign
10. American Diabetes Association Receives $450,000 Grant From Abbott Fund for Latino Community Initiatives
11. Abbott Releases 2007 Global Citizenship Report Highlighting Strong Commitment to Access to Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... , ... Alcovit, a lime-flavored beverage that rids the body of toxins linked ... now available through Jet.com. , After 25 years of development, the company released ... to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re having fun with ...
(Date:8/18/2017)... ... August 18, 2017 , ... “Dangerous Inheritance”: a mystery about saving the family ... is from Southwest Nebraska where she was raised on a farm. As Diane ... is fictional, but the friendships and mantra of ‘neighbors helping neighbors’ have always been ...
(Date:8/18/2017)... ... August 18, 2017 , ... Rollon Skin ... anti-aging skincare solutions, recently announced the launch of two new skincare products, ... yet effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... the Coatesville Veterans Affairs Medical Center. “Case #10-5411 Veterans Administration” is the ... of domestic abuse. In June 1990, Carol Mulhem started work at the ...
(Date:8/17/2017)... , ... August 17, 2017 , ... When Amy ... stretcher side nurse, she took with her a dream to make nursing education more ... Specifically, ensuring communication skills were integrated into healthcare provider education. , ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical company focused on ... the second quarter ended June 30, 2017. ... to date: Continued ... lead project, BL-8040: Announced plans to ... stem cell mobilization treatment for autologous bone-marrow transplantation in ...
(Date:8/7/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s largest independent specialty ... 2017.  All comparisons, unless otherwise noted, are to the quarter ... Second Quarter 2017 Highlights include: ... of 3.5% Total prescriptions dispensed of 220,000, ... versus 7.6% Gross profit per prescription ...
(Date:8/2/2017)... 2, 2017 Fenita J. Caldwell ... a Pinnacle Lifetime Professional in the Field of ... at Turing Pharmaceuticals, AG. Her skills and areas ... building.                ... years of experience as a highly successful sales ...
Breaking Medicine Technology: